A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Extracts of Selected South African Medicinal Plants Mitigate Virulence Factors in Multidrug-Resistant Strains of . | LitMetric

Extracts of Selected South African Medicinal Plants Mitigate Virulence Factors in Multidrug-Resistant Strains of .

Evid Based Complement Alternat Med

Division of Microbiology, Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Private Bag X20, Hatfield Pretoria 0028, South Africa.

Published: October 2023

The emergence of multidrug-resistant (MDR) remains a global health threat due to its alarming rates of becoming resistant to antibiotics. Therefore, identifying plant-based treatment options to target this pathogen's virulence factors is a priority. This study examined the antivirulence activities of twelve plant extracts obtained from three South African medicinal plants (, and ) against carbapenem-resistant (CBR) and extended-spectrum beta-lactamase (ESBL) positive strains. The plant extracts (ethyl acetate, dichloromethane, methanol, and water) were validated for their inhibitory activities against bacterial growth and virulence factors such as biofilm formation, exopolysaccharide (EPS) production, curli expression, and hypermucoviscosity. The potent extract on biofilm was observed with a scanning electron microscope (SEM), while exopolysaccharide topography and surface parameters were observed using atomic force microscopy (AFM). Chemical profiling of the potent extract was analysed using liquid chromatography-mass spectrometry (LC-MS). Results revealed a noteworthy minimum inhibitory concentration (MIC) value for the dichloromethane extract at 0.78 mg/mL on CBR- . (ethyl acetate) showed the highest cell attachment inhibition (67.25%) for CBR- SEM correlated the findings, evidenced by a significant alteration of the biofilm architecture. The highest EPS reduction of 34.18% was also noted for (ethyl acetate) and correlated by noticeable changes observed using AFM. (ethyl acetate) further reduced hypermucoviscosity to the least length mucoid string (1 mm-2 mm) at 1.00 mg/mL on both strains. (aqueous) showed biofilm inhibition of 45.91% for the ESBL-positive and inhibited curli expression at 0.50 mg/mL in both strains as observed for (aqueous) extract. Chemical profiling of (ethyl acetate), (aqueous), and (aqueous) identified diterpene (10.29%), hydroxy-dimethoxyflavone (10.24%), and 4,5-dicaffeoylquinic acid (13.41%), respectively, as dominant compounds. Overall, the ethyl acetate extract of revealed potent antivirulence properties against the studied MDR strains. Hence, it is a promising medicinal plant that can be investigated further to develop alternative therapy for managing -associated infections.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590271PMC
http://dx.doi.org/10.1155/2023/3146588DOI Listing

Publication Analysis

Top Keywords

ethyl acetate
24
virulence factors
12
south african
8
african medicinal
8
medicinal plants
8
plant extracts
8
curli expression
8
potent extract
8
chemical profiling
8
ethyl
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!